The AI-powered company is unlocking the hidden healing potential of plants by finding active compounds that could target specific conditions. Next up: diabetes and sleep disorders.
The person infected with the monkeypox virus is under isolation and receiving treatment at the expert infectious disease unit at the Guy’s and St Thomas’ National Health Services (NHS) Foundation Trust in London, England.
Former Cerebral vice president Matthew Truebe says the $4.8 billion company “consistently and at times egregiously put profits and growth before patient safety.”